 Hidradenitis Suppurativa
"Hidradenitis Suppurativa" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic suppurative and cicatricial disease of the apocrine glands occurring chiefly in the axillae in women and in the groin and anal regions in men. It is characterized by poral occlusion with secondary bacterial infection, evolving into abscesses which eventually rupture. As the disease becomes chronic, ulcers appear, sinus tracts enlarge, fistulas develop, and fibrosis and scarring become evident.
| Descriptor ID |
D017497
|
| MeSH Number(s) |
C01.252.825.420 C01.539.800.720.420 C01.539.830.499 C17.800.838.765.420 C17.800.946.315.320
|
| Concept/Terms |
Hidradenitis Suppurativa- Hidradenitis Suppurativa
- Hidradenitides, Suppurative
- Suppurative Hidradenitides
- Suppurative Hidradenitis
- Acne Inversa
- Acne Inversas
- Inversa, Acne
- Inversas, Acne
- Hidradenitis, Suppurative
|
Below are MeSH descriptors whose meaning is more general than "Hidradenitis Suppurativa".
Below are MeSH descriptors whose meaning is more specific than "Hidradenitis Suppurativa".
This graph shows the total number of publications written about "Hidradenitis Suppurativa" by people in this website by year, and whether "Hidradenitis Suppurativa" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 0 | 1 | | 2013 | 2 | 0 | 2 | | 2016 | 1 | 0 | 1 | | 2017 | 1 | 0 | 1 | | 2020 | 2 | 0 | 2 | | 2022 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Hidradenitis Suppurativa" by people in Profiles.
-
Coleman MS, Mulligan KM, O'Connell KA, Ahmad A, Kim L, da Silva A, Newton J, Dellavalle RP. Review of therapeutic trends in clinical trials for hidradenitis suppurativa: the?rise of biologics and demographic under-representation. Clin Exp Dermatol. 2024 Jan 25; 49(2):172-173.
-
Mastacouris N, Tannenbaum R, Strunk A, Koptyev J, Aarts P, Alhusayen R, Bechara FG, Benhadou F, Bettoli V, Brassard A, Brown D, Choon SE, Coutts P, da Silva DLF, Daveluy S, Dellavalle RP, Del Marmol V, Emtestam L, Gebauer K, George R, Giamarellos-Bourboulis EJ, Goldfarb N, Hamzavi I, Hazen PG, Horv?th B, Hsiao J, Ingram JR, Jemec GBE, Kirby JS, Lowes MA, Marzano AV, Matusiak L, Naik HB, Okun MM, Oon HH, Orenstein LAV, Paek SY, Pascual JC, Fernandez-Pe?as P, Resnik BI, Sayed CJ, Thorlacius L, van der Zee HH, van Straalen KR, Garg A. Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statement. JAMA Dermatol. 2023 11 01; 159(11):1258-1266.
-
Gallagher C, Mahon JM, O'Neill C, Cassidy FC, Dunbar H, De Barra C, Cadden C, Pisarska MM, Wood NAW, Masterson JC, McNamee EN, Schrumpf E, English K, O'Shea D, Tobin AM, Hogan AE. Mucosal-Associated Invariant T Cells Are Altered in Patients with Hidradenitis Suppurativa and Contribute to the Inflammatory Milieu. J Invest Dermatol. 2023 06; 143(6):1094-1097.e2.
-
Wang CX, Buss JL, Keller M, Anadkat MJ. Factors Associated With Dermatologic Follow-up vs Emergency Department Return in Patients With Hidradenitis Suppurativa After an Initial Emergency Department Visit. JAMA Dermatol. 2022 12 01; 158(12):1378-1386.
-
Steele AW, Miller NF, Wallace SJ, Hume KM, Sommers CA, Simmons CJ, Murphy RX. Hidradenitis Suppurativa: A Comparison of Institutional Experience and the Tracking Operations and Outcomes for Plastic Surgeons Registry. Plast Reconstr Surg. 2022 05 01; 149(5):1216-1224.
-
McBride O, McLean D, Samardzic T, Yannuzzi C, Guilbault S, Sayed C, Resnik B, Sisic M, Dellavalle RP, Tan J. Development of a hidradenitis suppurativa patient decision aid. Dermatol Online J. 2020 Nov 15; 26(11).
-
Kanni T, Argyropoulou M, Dinarello CA, Simard J, Giamarellos-Bourboulis EJ. MABp1 targeting interleukin-1a in hidradenitis suppurativa ineligible for adalimumab treatment: results of the open-label extension period. Clin Exp Dermatol. 2021 Jan; 46(1):162-163.
-
Ashrafzadeh S, Kim Y, Peters GA, Lee H, Asgari MM. Risk of keratinocyte carcinoma among patients with hidradenitis suppurativa. Br J Dermatol. 2020 11; 183(5):962-964.
-
Gupta MA, Vujcic B, Sheridan AD, Gupta AK. Reduced risk of suicidal behaviours associated with the treatment of hidradenitis suppurativa with tumour necrosis factor alpha antagonists: results from the US FDA Adverse Events Reporting System pharmacovigilance database. J Eur Acad Dermatol Venereol. 2020 Jul; 34(7):1564-1568.
-
Thorlacius L, Ingram JR, Villumsen B, Esmann S, Kirby JS, Gottlieb AB, Merola JF, Dellavalle R, Nielsen SM, Christensen R, Garg A, Jemec GBE. A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process. Br J Dermatol. 2018 09; 179(3):642-650.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|